Onyx is building a virtual immune system for faster and safer development of precision medicines. Our research studies deeply profile autoimmune diseases by vertically integrating multiomics data with longitudinal patient records.

Data equity pledge

Members who join our studies will have the chance to share revenue generated with their data. AI lets us model biology, but it only works because of the data that our members contribute.

How we work.

01. Members join research studies by sharing health records and contributing samples for scientific study.

02. Life scientists and AI researchers analyze samples and health records to develop new medicines.

03. Members receive a portion of revenue made using their data plus other membership benefits.

Current studies.

Rheumatoid Arthritis

Ankylosing Spondylitis

Systemic Sclerosis

More studies coming soon. Join our email list.

Founders

Roger Chen

Amit Lakhani